
TY  - JOUR
A1  - Heyworth, Peter 
T1  - Bevacizumab for blinding eye disease – is it time for the PBS to list for off-label use?
JF  - Australian Health Review
JO  - Aust. Health Review
Y1  - 2022
VL  - 46
IS  - 2
SP  - 150
EP  - 152
KW  - 
UR  - https://doi.org/10.1071/AH21379 
N2  - 
ER  -

